Question 1

Berapa harga saham Global Partners LP hari ini?

Accepted Answer

Harga saat ini dari Global Partners LP adalah 50.26 USD — harga tersebut telah meningkat sebesar 2.07% dalam 24 jam terakhir. Pantau kinerja harga saham Global Partners LP lebih dekat di grafik lanjutan.

Question 2

Apa simbol saham Global Partners LP?

Accepted Answer

Tergantung pada bursa, simbol saham bisa berbeda. Misalnya, di bursa NYSE, saham Global Partners LP diperdagangkan dengan simbol GLP.

Question 3

Apakah harga saham GLP naik?

Accepted Answer

Saham GLP telah meningkat sebesar 1.56% dalam seminggu terakhir, telah meningkat sebesar 9.98% dalam sebulan terakhir, dan telah meningkat sebesar 0.88% dalam setahun terakhir. Lihat lebih banyak data di grafik GLP.

Question 4

Apa rekomendasi analis untuk GLP?

Accepted Answer

Hingga 22 mag 2026, dari 2 rekomendasi analis, mayoritas memberikan rating GLP sebagai hold.

Question 5

Apa kapitalisasi pasar GLP?

Accepted Answer

Hingga hari ini, GLP memiliki kapitalisasi pasar sebesar 1.66B USD. Jelajahi daftar saham kami yang diperingkat berdasarkan kapitalisasi pasar untuk membandingkan GLP dengan saham lainnya.

Question 6

Apakah GLP merilis laporan keuangan?

Accepted Answer

Ya, Anda dapat melacak keuangan GLP dalam laporan tahunan dan kuartalan di Profit.com.

Question 7

Kapan tanggal laporan pendapatan GLP berikutnya?

Accepted Answer

GLP akan merilis laporan pendapatan berikutnya pada -. Pantau acara yang akan datang dengan Kalender Pendapatan kami.

Question 8

Berapa pendapatan GLP untuk kuartal terakhir?

Accepted Answer

GLP melaporkan pendapatan sebesar $0.54 per saham untuk kuartal terakhir, lebih rendah dibandingkan dengan estimasi $0.96 per saham, yang menghasilkan kejutan -43.75%. Estimasi pendapatan untuk kuartal berikutnya adalah $0.33 per saham. Lihat lebih banyak rincian tentang pendapatan GLP di Profit.com.

Question 9

Berapa pendapatan GLP untuk kuartal terakhir?

Accepted Answer

Pendapatan GLP untuk kuartal terakhir adalah 5.32B USD, lebih rendah dibandingkan dengan estimasi 7.46B USD. Estimasi pendapatan untuk kuartal berikutnya adalah 7.06B USD. Lihat lebih banyak statistik di laporan keuangan GLP di Profit.com.

Question 10

Berapa Laba Bersih GLP untuk kuartal terakhir?

Accepted Answer

Pendapatan bersih GLP untuk kuartal terakhir adalah 64.74M USD, sementara kuartal sebelumnya menunjukkan 20.13M USD laba bersih yang mencatatkan perubahan 221.70%. Lihat lebih banyak statistik di laporan keuangan GLP di Profit.com.

Question 11

¿GLP paga dividendos?

Accepted Answer

Sí, los dividendos de GLP se pagan trimestralmente. El último dividendo por acción fue 3.03. A partir de hoy, el rendimiento por dividendo (TTM)% es 6.20%.

Question 12

¿Cuántos empleados tiene GLP?

Accepted Answer

A partir de 22 mag 2026, GLP emplea aproximadamente a 3265 empleados. Consulta si GLP está en nuestra lista de empleadores más grandes.

Question 13

¿Qué es el EBITDA de GLP?

Accepted Answer

El EBITDA, que mide el rendimiento operativo de una empresa, refleja sus mejoras en eficiencia. El EBITDA de GLP es 422.81M USD, con un margen EBITDA actual de 0.67%. Consulta más estadísticas en los rapporti finanziari de GLP en Profit.com.

Question 14

¿Cómo comprar acciones de GLP?

Accepted Answer

Al igual que otras acciones, las acciones de GLP se cotizan en bolsas de valores como NYSE. La forma más fácil de comprarlas es a través de un bróker de bolsa en línea. Simplemente abre una cuenta, sigue los procedimientos del bróker y comienza a operar. Alternativamente, puedes practicar comerciando acciones de Tesla en Profit.com en torneos Playtrade o elegir un bróker recomendado para operar directamente.

Question 15

¿Debería invertir en las acciones de GLP?

Accepted Answer

Invertir en acciones requiere una investigación exhaustiva, que incluye analizar las finanzas de la empresa, las noticias relacionadas y el análisis técnico. Actualmente, las recomendaciones de los analistas técnicos de Tesla muestran una calificación de hold.

Antes de invertir en GLP, considera suscribirte a Profit PRO, donde puedes practicar el comercio en torneos Playtrade, acceder a informes diarios de mercado impulsados por IA, copiar listas de seguimiento cuidadosamente seleccionadas y seguir los portafolios de los multimillonarios.

Global Partners LP

Amazon launches GLP-1 weight loss program, promising'fast, convenient' access

Eli Lilly taps into its GLP-1 windfall, while Honeywell sheds a lower-margin unit

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC

As millions lose weight on GLP-1s, they're starting to turn to retailers to refresh their wardrobes

Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says - CNBC

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

Fancy clothes, mealtime alarms and Disney princess gigs: How GLP-1s are changing people's lives in unexpected ways

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

What the initial frenzy over GLP-1 drugs can teach us about the current market

What signal Lilly sends by stockpiling its GLP-1 weight loss pills ahead of FDA approval

Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

This top stock-picker spotted Nvidia and GLP-1s early — and made over 200%. Here’s what he’s buying now.

Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead

Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs

Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs

FDA approves first GLP-1 pill for weight loss - Axios

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk - CNBC

GRVT GLP Strategy Reopened, Funding Cap Raised to $7.5M on Grvt’s Decentralized Perpetual Platform

There’s still hope GLP-1 drugs could slow the second-biggest type of dementia

Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, and the stock tumbles

Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joined the $1 trillion market cap club.

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s

Tariffs and GLP-1s are keeping people from dining out. An analyst tries to find the positives.

GLP-1 drugs could save millions of lives — and spark a pension crisis

Hacked Perp DEX GMX to Repay $44M to Arbitrum GLP Holders After Exploit

Why GLP-1s could become the "everything drug" - Axios

GMX Recovers $42 Million GLP Funds on Arbitrum After V1 Vulnerability Attack

GMX Hack Exploits GLP Token Vulnerability, Potential Partial Recovery of Stolen Ethereum

GMX Faces $40 Million V1 GLP Pool Exploit, Raising Questions on DeFi Leverage Security

GMX V1 Faces Possible Exploit Impacting GLP Pool Amid Ongoing Crypto Security Concerns in 2025

GMX V1 GLP Pool on Arbitrum Hit by $40M Attack; Trading Suspended to Protect Users

Market Voices: July Fed rate cut eyed, GLP-1s, Darden, Aflac, JPMorgan

Just how many Americans are taking GLP-1s now - Axios

Hims & Hers shares tumble 18% as margin miss adds to concerns about GLP-1 business

Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease - Fortune

What's next for GLP-1 weight-loss drugs in 2025? https://t.co/LPstciGZ32 https://t.co/mVitY14CTY

Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’

WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering

Obesity drugs in kindergarten? Novo Nordisk GLP-1 drug works for kids as young as 6, study finds.

Obesity drugs’ next wave: These companies could snag 20% of GLP-1 market, analysts say

For Alzheimer’s patients, this Novo Nordisk GLP-1 drug slows cognitive decline, study finds

Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says - CNBC

Zealand Pharma shares surge after positive results of weight-loss drug that could contend with GLP-1s

Ares Management exploring deal with GLP Capital Partners - Bloomberg

Healthy Returns: 1 in 8 adults have taken Ozempic or other GLP-1s, survey says - CNBC

GLP Capital Partners raises $1.4 bln for its China Income Fund XII https://t.co/qtW1H4tSch https://t.co/eFTinyLBlC

LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs

FAQ